[go: up one dir, main page]

RU99118589A - A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML CONTAINING BUDESONIDE - Google Patents

A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML CONTAINING BUDESONIDE

Info

Publication number
RU99118589A
RU99118589A RU99118589/14A RU99118589A RU99118589A RU 99118589 A RU99118589 A RU 99118589A RU 99118589/14 A RU99118589/14 A RU 99118589/14A RU 99118589 A RU99118589 A RU 99118589A RU 99118589 A RU99118589 A RU 99118589A
Authority
RU
Russia
Prior art keywords
composition
inhalation
volume density
filling volume
bulk density
Prior art date
Application number
RU99118589/14A
Other languages
Russian (ru)
Other versions
RU2180563C2 (en
Inventor
Ян Трофаст
Original Assignee
Астра Актиеболаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9700133A external-priority patent/SE9700133D0/en
Application filed by Астра Актиеболаг filed Critical Астра Актиеболаг
Publication of RU99118589A publication Critical patent/RU99118589A/en
Application granted granted Critical
Publication of RU2180563C2 publication Critical patent/RU2180563C2/en

Links

Claims (7)

1. Сухая порошкообразная композиция, содержащая будесонид и вещество-носитель, которые находятся в тонко измельченной форме и по существу однородно распределены, причем эта композиция имеет насыпную объемную плотность 0,28 - 0,38 г/мл.1. A dry powder composition containing budesonide and a carrier substance that are in finely divided form and substantially uniformly distributed, the composition having a bulk density of 0.28-0.38 g / ml. 2. Композиция по п. 1, где объемная плотность составляет 0,30 - 0,36 г/мл. 2. The composition of claim 1, wherein the bulk density is 0.30-0.36 g / ml. 3. Композиция по п. 1 или 2 для применения при лечении респираторного расстройства. 3. The composition of claim 1 or 2 for use in the treatment of a respiratory disorder. 4. Способ получения композиции по п. 1, при котором: (a) микронизируют будесонид и вещество-носитель; (б) возможно приводят этот продукт в соответствие с нормами; и (в) сферонизируют до тех пор, пока не будет получена желаемая объемная плотность. 4. A method of obtaining a composition according to claim 1, wherein: (a) budesonide and a carrier substance are micronized; (b) it is possible to bring this product into compliance with the standards; and (c) spheronized until the desired bulk density is obtained. 5. Способ по п. 4, который включает в себя стадию повторной микронизации низкой энергии после стадии (б). 5. The method according to p. 4, which includes the stage of re-micronization of low energy after stage (b). 6. Применение композиции по п. 1 или 2 в производстве лекарства для использования в терапии. 6. The use of a composition according to claim 1 or 2 in the manufacture of a medicament for use in therapy. 7. Способ лечения пациента, страдающего респираторным расстройством, при котором пациенту вводят терапевтически эффективное количество композиции по п. 1 или 2. 7. A method of treating a patient suffering from a respiratory disorder in which a therapeutically effective amount of a composition according to claim 1 or 2 is administered to a patient.
RU99118589/14A 1997-01-20 1998-01-13 Preparation for inhalation with filled volume density from 0,28 to 0,38 g/ml containing budesonide RU2180563C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700133-3 1997-01-20
SE9700133A SE9700133D0 (en) 1997-01-20 1997-01-20 New formulation

Publications (2)

Publication Number Publication Date
RU99118589A true RU99118589A (en) 2001-06-27
RU2180563C2 RU2180563C2 (en) 2002-03-20

Family

ID=20405452

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99118589/14A RU2180563C2 (en) 1997-01-20 1998-01-13 Preparation for inhalation with filled volume density from 0,28 to 0,38 g/ml containing budesonide

Country Status (35)

Country Link
US (1) US6027714A (en)
EP (1) EP1019033B1 (en)
JP (1) JP2010059179A (en)
KR (1) KR100528418B1 (en)
CN (1) CN1222282C (en)
AT (1) ATE389390T1 (en)
AU (1) AU726916B2 (en)
BE (1) BE1011400A5 (en)
BR (1) BR9806892A (en)
CA (1) CA2277914C (en)
CZ (1) CZ295083B6 (en)
DE (1) DE69839275T2 (en)
DK (1) DK1019033T3 (en)
EE (1) EE03998B1 (en)
ES (2) ES2302348T3 (en)
FR (1) FR2759908B1 (en)
GR (1) GR1003290B (en)
HK (1) HK1025516A1 (en)
HU (1) HU228312B1 (en)
ID (1) ID22883A (en)
IE (1) IE980024A1 (en)
IL (1) IL130840A (en)
IS (1) IS2563B (en)
NL (1) NL1008019C2 (en)
NO (1) NO327451B1 (en)
NZ (1) NZ336592A (en)
PL (1) PL191569B1 (en)
PT (1) PT1019033E (en)
RU (1) RU2180563C2 (en)
SE (1) SE9700133D0 (en)
SI (1) SI1019033T1 (en)
SK (1) SK283948B6 (en)
TR (1) TR199901691T2 (en)
UA (1) UA57762C2 (en)
WO (1) WO1998031350A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803770D0 (en) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
EP1129705A1 (en) 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
FR2809692A1 (en) 2000-05-31 2001-12-07 Ecia Equip Composants Ind Auto Cover assembly for vehicle air bag, has rigid structural element with line of reduced resistance to outline flap, and form rupture line and hinge, formed by flexible layer stuck on to structural layer
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
SE0200657D0 (en) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN100333727C (en) * 2004-11-25 2007-08-29 天津药业研究院有限公司 Budesonide target-direction microball and preparation thereof
ES2493641T3 (en) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Nasal administration of aqueous corticosteroid solutions
DE102007049931A1 (en) 2007-10-18 2009-04-23 Pharmatech Gmbh Apparatus and method for the continuous production of spherical powder agglomerates
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
PL2821061T3 (en) 2013-07-01 2018-05-30 Arven Ilac Sanayi Ve Ticaret A.S. Novel inhalation formulations
CA3073195A1 (en) 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
CN114514020A (en) 2019-09-24 2022-05-17 奇斯药制品公司 Novel carrier particles for dry powder formulations for inhalation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
SE438261B (en) * 1981-07-08 1985-04-15 Draco Ab USE IN A DOSHALATOR OF A PERFORED MEMBRANE
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
DE69027319T2 (en) * 1989-04-28 1996-11-21 Riker Laboratories Inc., Northridge, Calif. INHALATION DEVICE FOR DRY POWDER
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
SE9100341D0 (en) * 1991-02-04 1991-02-04 Astra Ab NOVEL STEROIDS
SE9100342D0 (en) * 1991-02-04 1991-02-04 Astra Ab NOVEL STEROID ESTERS
SE9101090D0 (en) * 1991-04-11 1991-04-11 Astra Ab PROCESS FOR CONDITIONING OF WATER-SOLUBLE SUBSTANCES
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
PT656206E (en) * 1991-06-10 2001-11-30 Schering Corp AEROSOLS FORMULATIONS WITHOUT CHLOROFLUOROCARBONETS
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DK0613371T3 (en) * 1991-12-18 2002-05-13 Astrazeneca Ab New combination of formoterol and budesonide
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
CA2147283C (en) * 1992-10-16 2007-01-16 Kouichi Nakamichi Method of manufacturing wax matrices
PL175564B1 (en) * 1993-10-01 1999-01-29 Astra Ab Process i
IS1736B (en) * 1993-10-01 1999-12-30 Astra Ab Methods and devices that promote increased particle aggregation
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
RU2147226C1 (en) * 1994-09-29 2000-04-10 Квадрант Хэлткэа (Ю Кей) Лимитед Microparticles dried by spraying as therapeutic carriers
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
RU2071317C1 (en) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Medicinal powder-like preparation for inhalation
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
SE9603669D0 (en) * 1996-10-08 1996-10-08 Astra Ab New combination

Similar Documents

Publication Publication Date Title
RU99118587A (en) A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, METHOD OF ITS PRODUCTION AND ITS APPLICATION
RU99118589A (en) A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML CONTAINING BUDESONIDE
RU99118588A (en) A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING FORMOTEROL
US4193985A (en) Multiple-units drug dose
KR100329249B1 (en) Nasal administration composition
US6616914B2 (en) Method for pulmonary and oral delivery of pharmaceuticals
EE03221B1 (en) Pharmaceutical formulations for inhalation, the process for their preparation and the inhaler for their use
IL113651A0 (en) Pharmaceutical compositions containing alendronate and their use
SK12792001A3 (en) Pharmaceutical composition for treating neurointoxications, preparation containing xenon or xenon gas mixture and method for producing an inhalation agent
RU99118586A (en) A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING TERBUTALINE SULFATE, METHOD FOR PRODUCING AND ITS APPLICATION
RU2001123923A (en) Compositions comprising formoterol and tiotropium salt
EA200100338A1 (en) METHOD AND DEVICE FOR INTRODUCTION OF EXISTING SUBSTANCE IN THE FORM OF AEROSOL IN LUNG PATIENT
CA2402169A1 (en) Formulation and method for treating neoplasms by inhalation
US20230001128A1 (en) Aerosolization systems, methods, and apparatuses
PL342825A1 (en) Inhaler for podwery substances
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
EE04038B1 (en) Formoterol inhalation dosage form, bulk density 0.28 to 0.38 g / ml, method of preparation and use
EE9900293A (en) New inhaled terbutaline sulphate dosage form, bulk density 0.28 to 0.38 g / ml, process for its preparation and use
US20240123168A1 (en) Product delivery devices and methods
RU2002124141A (en) APPLICATION OF MIRTAZAPINE FOR TREATMENT OF SLEEP DISORDERS
RU2394579C2 (en) Application of ethinylestradiol and chlormadinone acetate combination for preparation of medication
FI86375C (en) FOERFARANDE FOER FRAMSTAELLNING AV BINDEMEDELFRITT TABLETTERINGSDUGLIGT CELIPROLOLHYDROKLORIDGRANULAT.
JPS6442423A (en) Remedy containing propaphenone antipode
RU2193884C2 (en) Method for premedication in patients with cardiovascular pathology at outpatient stomatological interference